0.45
Kymera Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
0.42
FY23:
0.41
FY24:
0.51
FY25:
0.87
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.15
FY22:
0.18
FY23:
0.17
FY24:
0.47
FY25:
0.87
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.61
FY22:
0.60
FY23:
0.58
FY24:
0.98
FY25:
1.74
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.07
FY23:
0.09
FY24:
0.07
FY25:
0.08
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.05
FY22:
0.04
FY23:
0.10
FY24:
0.07
FY25:
0.08
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.46
FY22:
0.49
FY23:
0.39
FY24:
0.84
FY25:
1.58
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.61
FY22:
0.60
FY23:
0.58
FY24:
0.98
FY25:
1.74
All amounts in billions USD